Fulcrum Therapeutics, Inc. (FULC)
3.78
+0.02
(+0.53%)
USD |
NASDAQ |
Sep 21, 09:36
Fulcrum Therapeutics Net Income (TTM) : -85.00M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -85.00M |
| March 31, 2026 | -76.12M |
| December 31, 2025 | -74.88M |
| September 30, 2025 | -71.11M |
| June 30, 2025 | -73.22M |
| March 31, 2025 | -0.51M |
| December 31, 2024 | -9.725M |
| September 30, 2024 | -17.91M |
| June 30, 2024 | -20.23M |
| March 31, 2024 | -99.43M |
| December 31, 2023 | -97.34M |
| September 30, 2023 | -98.71M |
| June 30, 2023 | -98.44M |
| March 31, 2023 | -108.72M |
| December 31, 2022 | -109.87M |
| September 30, 2022 | -107.22M |
| Date | Value |
|---|---|
| June 30, 2022 | -104.20M |
| March 31, 2022 | -89.78M |
| December 31, 2021 | -80.85M |
| September 30, 2021 | -75.08M |
| June 30, 2021 | -73.33M |
| March 31, 2021 | -69.37M |
| December 31, 2020 | -70.82M |
| September 30, 2020 | -69.22M |
| June 30, 2020 | -66.80M |
| March 31, 2020 | -64.29M |
| December 31, 2019 | -82.68M |
| September 30, 2019 | -75.41M |
| June 30, 2019 | -67.81M |
| March 31, 2019 | -62.49M |
| December 31, 2018 | -32.59M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Cocrystal Pharma, Inc. | -9.938M |
| CNBX Pharmaceuticals, Inc. | -0.4621M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 9.30M |
| Definium Therapeutics, Inc. | -353.78M |